2013
DOI: 10.1111/apt.12528
|View full text |Cite
|
Sign up to set email alerts
|

Nationwide prevalence of inflammatory bowel disease in Sweden: a population-based register study

Abstract: SUMMARY BackgroundRegional studies on inflammatory bowel disease (IBD) suggest an increasing prevalence over time, but no nationwide estimate has been published so far.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

10
89
1

Year Published

2014
2014
2022
2022

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 121 publications
(104 citation statements)
references
References 38 publications
10
89
1
Order By: Relevance
“…In the Western society the prevalence of inflammatory bowel disease is approaching 1% and in Sweden the percentage is around 0.65%. [205]. IBD is divided into ulcerative colitis (UC), Crohn's disease (CD), microscopic colitis (MC) and indeterminate colitis.…”
Section: Inflammatory Bowel Disease and Microscopic Colitismentioning
confidence: 99%
“…In the Western society the prevalence of inflammatory bowel disease is approaching 1% and in Sweden the percentage is around 0.65%. [205]. IBD is divided into ulcerative colitis (UC), Crohn's disease (CD), microscopic colitis (MC) and indeterminate colitis.…”
Section: Inflammatory Bowel Disease and Microscopic Colitismentioning
confidence: 99%
“…This is the first survey in Sweden on treatment with TNF inhibitors in IBD, a country where the prevalence of IBD is approaching 0.7% [1] . Anti-TNF treatment in IBD is constantly evolving and it is now 5 years since the last survey regarding practice patterns of anti-TNF treatment in IBD was conducted in Europe [7] .…”
Section: Discussionmentioning
confidence: 99%
“…Crohn's disease and ulcerative colitis are chronic inflammatory disorders that affect more than 60,000 people in Sweden [1] . Here, anti-TNF-α antibodies have been used in the treatment of Crohn's disease (CD) since 1999 and in recent years also in the treatment of ulcerative colitis (UC).…”
Section: Introductionmentioning
confidence: 99%
“…Abdulkader Mohammed Albasri regarding IBD, there is abundant scientific material on epidemiology and related parameters from the Western and developed world (Lakatos et al, 2011;Mangat et al, 2011;Achitei et al, 2013;Klarin et al, 2013;Penn et al, 2013;Burisch., 2014;Busch et al, 2014;Golovics et al, 2014, Ko et al, 2014Nguyen et al, 2014;Norgard et al, 2014). Asian scientists have contributed to IBD literature significantly suring the last five years (Ahuja & Tandon, 2010;Al-Jashamy et al, 2010;Ren & Fang, 2011;Ng et al, 2013;Wei et al, 2013;Zeng et al, 2013;Huai et al, 2014;Kasturiratne et al, 2014).…”
Section: Histopathological Profile Of Benign Colorectal Diseases In Amentioning
confidence: 99%